Think Bioscience

Boulder, United States Founded: 2019 • Age: 7 yrs
Synthetic biology platform is utilized to develop small-molecule therapeutics.

About Think Bioscience

Think Bioscience is a company based in Boulder (United States) founded in 2019 by Jerome Fox and Philip Jeng.. Think Bioscience has raised $78 million across 4 funding rounds from investors including YK Bioventures, America’s Seed Fund and Innovation Endeavors. The company has 21 employees as of December 31, 2022. Think Bioscience offers products and services including Small-Molecule Drugs and Synthetic Biology Platform. Think Bioscience operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.

  • Headquarter Boulder, United States
  • Employees 21 as on 31 Dec, 2022
  • Founders Jerome Fox, Philip Jeng
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Think Bioscience, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $78 M (USD)

    in 4 rounds

  • Latest Funding Round
    $55 M (USD), Series A

    Jan 20, 2026

  • Investors
  • Employee Count
    21

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Think Bioscience

Think Bioscience offers a comprehensive portfolio of products and services, including Small-Molecule Drugs and Synthetic Biology Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Develops drugs targeting challenging biomolecular mechanisms via synthetic biology techniques.

Platform for uncovering novel biomolecular engagement in drug research and development.

People of Think Bioscience
Headcount 10-50
Employee Profiles 16
Board Members and Advisors 9
Employee Profiles
People
Matt Traylor
Chief Scientific Officer
People
Philip Jeng
COO
People
Solomon Wilcox
Research Technician
People
Nickles Badger
Research Technician

Unlock access to complete

Board Members and Advisors
people
Jay Keasling
Advisor
people
Donna See
Board Member
people
Nick Saccomano
Advisor
people
Larry Burgess
Advisor

Unlock access to complete

Funding Insights of Think Bioscience

Think Bioscience has successfully raised a total of $78M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $55 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series A — $55.0M
  • First Round

    (15 Dec 2020)

  • Investors Count 15
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2026 Amount Series A - Think Bioscience Valuation Regeneron Ventures , Janus Henderson Investors
May, 2024 Amount Seed - Think Bioscience Valuation

investors

Aug, 2022 Amount Seed - Think Bioscience Valuation Innovation Endeavors , Xora Innovation
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Think Bioscience

Think Bioscience has secured backing from 15 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include YK Bioventures, America’s Seed Fund and Innovation Endeavors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Venture capital fund backed by the US Government
Founded Year Domain Location
Early-stage technology investments are targeted by this venture capital firm.
Founded Year Domain Location
Capital is provided by Xora to deep tech entrepreneurs.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Think Bioscience

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Think Bioscience

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Think Bioscience Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Think Bioscience

Think Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of renewable products for industrial solutions
domain founded_year HQ Location
Crop protection solutions and hybrid seeds are provided for farming.
domain founded_year HQ Location
Gene and protein therapies are developed for treating various diseases.
domain founded_year HQ Location
Gene editing-based cultured ingredients are provided for agriculture.
domain founded_year HQ Location
Yeast cells are genetically engineered to produce medicinal products.
domain founded_year HQ Location
Synthetic DNA is synthesized via a semiconductor-based platform.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Think Bioscience

Frequently Asked Questions about Think Bioscience

When was Think Bioscience founded?

Think Bioscience was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is Think Bioscience located?

Think Bioscience is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.

Who is the current CEO of Think Bioscience?

Jerome Fox is the current CEO of Think Bioscience. They have also founded this company.

Is Think Bioscience a funded company?

Think Bioscience is a funded company, having raised a total of $78M across 4 funding rounds to date. The company's 1st funding round was a Seed of $17M, raised on Dec 15, 2020.

How many employees does Think Bioscience have?

As of Dec 31, 2022, the latest employee count at Think Bioscience is 21.

What does Think Bioscience do?

Think Bioscience was founded in 2019 and is headquartered in Boulder, United States. A synthetic biology platform is offered by the company within the biotechnology sector, where applied microbiology, enzymology, and data science are integrated to create small-molecule therapeutics. Focus is placed on targeting difficult-to-drug proteins, supporting drug development operations through this interdisciplinary approach.

Who are the top competitors of Think Bioscience?

Think Bioscience's top competitors include Syngenta, Synthego and Antheia.

What products or services does Think Bioscience offer?

Think Bioscience offers Small-Molecule Drugs and Synthetic Biology Platform.

Who are Think Bioscience's investors?

Think Bioscience has 15 investors. Key investors include YK Bioventures, America’s Seed Fund, Innovation Endeavors, Xora, and AV8 Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available